Literature DB >> 3531333

The regulatory role of sialic acids in the response of class II reactive T cell hybridomas to allogeneic B cells.

S Taira, T Kakiuchi, M Minami, H Nariuchi, S Taiara.   

Abstract

Two different kinds of alloreactive T cell hybridomas were established in previous experiments. One is reactive and the other is nonreactive to allogeneic I-A region-associated membrane antigen (mIa) on B cells. In the present experiments the difference between these hybridomas were analyzed by using representative clones, B cell mIa-reactive clone CB-11.4, and nonreactive clone HTB-9.3. Unresponsiveness of HTB-9.3 clone to allogeneic B cells could not be due to the inability of B cells in interleukin 1 production or the density of mIa molecules on B cells. HTB-9.3 clone could respond to C57BL/6 mouse B cells treated with neuraminidase (Nase), and Nase-treated HTB-9.3 clone could respond to normal B cells from C57BL/6 mouse, indicating that sialic acid on both B cells and HTB-9.3 clone plays a regulatory role in the alloreactivity of the clone. In response to B cells from C57BL/6 mouse, T cells from C3H/He mouse spleen showed similar reactivity to HTB-9.3 clone; that is, T cells could respond to Nase-treated B cells, and Nase-treated T cells to B cells, and T cells primed with C57BL/6 spleen cells in vitro showed similar reactivity to CB-11.4 clone. These results suggest that HTB-9.3 clone represents virgin T cells and CB-11.4 clone-primed T cells at least in alloreactivity. Anti-L3T4a was shown to block alloreactivities of both T cell hybridomas and splenic T cells against B cells more efficiently than against splenic adherent cells. These results suggest that L3T4a on T cell plays more important role in allogeneic response to B cells than to splenic adherent cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3531333

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Monoclonal antibodies EBU-141 (CDw75) and EBU-65 allow reliable distinction between mature and pre-B-cell tumors in suspension and on tissue sections.

Authors:  M Gramatzki; R Burger; J Kraus; U Lauer; P Rohwer; G Eger; J R Kalden; F Henschke
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

2.  Augmentation of antigen-specific lymphoproliferative responses in vitro by biological response modifiers.

Authors:  T D de Gruijl; J J Moore; E de Vries; B M von Blomberg-van der Flier; J C Fonk; R J Scheper
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

3.  The B cell antigen CD75 is a cell surface sialytransferase.

Authors:  I Stamenkovic; H C Asheim; A Deggerdal; H K Blomhoff; E B Smeland; S Funderud
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.